A brief review of cardiovascular diseases, associated risk factors and current treatment regimes
Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in
humans and their incidence is on the rise globally. Given their substantial contribution …
humans and their incidence is on the rise globally. Given their substantial contribution …
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association
BW McCrindle, AH Rowley, JW Newburger, JC Burns… - circulation, 2017 - Am Heart Assoc
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …
[HTML][HTML] Timing of complete revascularization with multivessel PCI for myocardial infarction
BE Stähli, F Varbella, A Linke, B Schwarz… - … England Journal of …, 2023 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …
multivessel coronary artery disease, the time at which complete revascularization of …
Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care
These guidelines contain recommendations for basic life support (BLS) and advanced life
support (ALS) for adult patients and are based on the best available resuscitation science …
support (ALS) for adult patients and are based on the best available resuscitation science …
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management
JR Ghadri, IS Wittstein, A Prasad… - European Heart …, 2018 - academic.oup.com
The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the
diagnostic workup, outcome, and management. The recommendations are based on …
diagnostic workup, outcome, and management. The recommendations are based on …
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …
SM Al-Khatib, WG Stevenson, MJ Ackerman… - Journal of the American …, 2018 - jacc.org
The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …
evidence-based. An initial extensive evidence review, which included literature derived from …
[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of …
GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn… - Circulation, 2016 - Am Heart Assoc
The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …